The management of the National Agency for Food and Drug Administration and Control, NAFDAC, and the Centre for Drug Discovery, Development and Production, CDDDP, Faculty of Pharmacy, University of Ibadan have entered into an agreement aimed at controlling the sharp practices in the drug production sector in the country and improve the quality of drugs.
The signing of the Memorandum of Understanding (MoU), was part of the activities marking a recent three-day-old International Conference on Medicine Regulation organised by the centre in conjunction with United Kingdom-based company, Reckitt Benckiser.
The conference, themed: Medicine Regulation of Claims: From Concept to Launch, which held at the university’s Conference Centre, brought together members of the academia, pharmaceutical industry and regulators to chart a way forward in medicine regulation.
The Dean, Faculty of Pharmacy, Professor Chinedum Babalola, in her opening address said the conference was in response to the nation’s need to improve the existing linkage between academia and industry, noting that the faculty had always aimed at aiding the development of pharmaceutical industry in the country.
The NAFDAC Director General, Dr. Paul Orhi in his keynote address described the conference as historic and a right step in the right direction.
He emphasised the need for the gown and town to partner to address health challenges facing the country. He attributed the success of the MoU signed at the event to the commitment and dedication of the leadership of the Pharmacy department and its foresight.
The Managing Director of Reckitt Benckiser (West Africa), Rahul Murghai, lauded the industries’ commitment to the production of products capable of enhancing good health among the populace. The Centre for Drug Discovery Development and Production (CDDDP) also used the conference to invite applicants for Postgraduate Diploma in Drug Development (PDDD).